Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient-Reported Outcomes (PROs) in HIV Infection: Points to Consider and Challenges.
Antela A, Bernardino JI, de Quirós JCL, Bachiller P, Fuster-RuizdeApodaca MJ, Puig J, Rodríguez S, Castrejón I, Álvarez B, Hermenegildo M. Antela A, et al. Among authors: castrejon i. Infect Dis Ther. 2022 Oct;11(5):2017-2033. doi: 10.1007/s40121-022-00678-w. Epub 2022 Sep 6. Infect Dis Ther. 2022. PMID: 36066841 Free PMC article.
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network.
Hellamand P, van de Sande MGH, Ørnbjerg LM, Klausch T, Eklund KK, Relas H, Santos MJ, Vieira-Sousa E, Loft AG, Glintborg B, Østergaard M, Lindström U, Wallman JK, Michelsen B, Fagerli KM, Castrejón I, Gudbjornsson B, Love TJ, Vencovský J, Nekvindová L, Rotar Ž, Tomšič M, Díaz-González F, Kenar G, Tuğsal HY, Iannone F, Ramonda R, Codreanu C, Mogosan C, Nissen MJ, Möller B, Hetland ML, van der Horst-Bruinsma IE. Hellamand P, et al. Among authors: castrejon i. Arthritis Rheumatol. 2024 Apr;76(4):587-598. doi: 10.1002/art.42758. Epub 2024 Feb 25. Arthritis Rheumatol. 2024. PMID: 37975166
Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry.
Valero M, Sánchez-Piedra C, Freire M, Colazo M, Busquets N, Meriño-Ibarra E, Rodríguez-Lozano C, Manrique S, Campos C, Sánchez-Alonso F, Castrejón I. Valero M, et al. Among authors: castrejon i. Arthritis Res Ther. 2023 May 22;25(1):86. doi: 10.1186/s13075-023-03045-3. Arthritis Res Ther. 2023. PMID: 37217997 Free PMC article.
Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry.
Calvo-Gutiérrez J, López-Medina C, Otero-Varela L, Escudero-Contreras A, Ortega-Castro R, Ladehesa-Pineda L, Campos C, Bernabeu-Gonzalvez P, Pérez-Gómez A, García-Dorta A, Ruiz-Montesino D, Pombo-Suarez M, Ros-Vilamajo I, Sánchez-Alonso F, Castrejón I. Calvo-Gutiérrez J, et al. Among authors: castrejon i. Arthritis Res Ther. 2024 Feb 23;26(1):57. doi: 10.1186/s13075-024-03287-9. Arthritis Res Ther. 2024. PMID: 38395899 Free PMC article.
121 results